Anacor Pharma takes bigger 4Q loss connected costs CBS News Its drug candidates include tavaborole, which is designed to treat a common unhealthiness of the nail and nail bed, and AN2728, a potential treatment for atopic dermatitis and disease of the skin . The company dressed enrolling patients in ii late-stage trials of ... Anacor Pharmaceuticals Reports 2011 Fourth Quarter and Year-End Financial Results MarketWatch (press release) all 10 tidings articles » Link To Article
No comments:
Post a Comment